X0306 4 2021-02-22 0001682852 Moderna, Inc. MRNA 0001690927 Zaks Tal Zvi C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 Chief Medical Officer Common Stock 2021-02-22 4 M 0 5000 12.21 A 5000 D Common Stock 2021-02-22 4 S 0 263 159.32 D 4737 D Common Stock 2021-02-22 4 S 0 100 160.38 D 4637 D Common Stock 2021-02-22 4 S 0 800 162.47 D 3837 D Common Stock 2021-02-22 4 S 0 1100 163.57 D 2737 D Common Stock 2021-02-22 4 S 0 300 164.60 D 2437 D Common Stock 2021-02-22 4 S 0 1000 165.95 D 1437 D Common Stock 2021-02-22 4 S 0 700 166.82 D 737 D Common Stock 2021-02-22 4 S 0 356 168.00 D 381 D Common Stock 2021-02-22 4 S 0 281 168.90 D 100 D Common Stock 2021-02-22 4 S 0 100 169.81 D 0 D Stock Option (Right to Buy) 12.21 2021-02-22 4 M 0 5000 0 D 2027-02-23 Common Stock 5000 6478 D The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.13 to $159.63. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $161.97 to $162.89. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $163.19 to $164.12. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $164.26 to $165.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $165.44 to $166.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $166.47 to $167.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $167.72 to $168.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $168.75 to $169.15. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter. /s/ Brian Sandstrom, as Attorney-in-Fact 2021-02-24